Alzheimer's Disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-Alzheimer's Disease-specific molecular biomarkers (ADSMB)

Details for Australian Patent Application No. 2009234405 (hide)

Owner Blanchette Rockefeller Neurosciences Institute

Inventors Alkon, Daniel L.; Khan, Tapan Kumar

Agent Davies Collison Cave

Pub. Number AU-A-2009234405

PCT Pub. Number WO2009/126232

Priority 12/078,857 07.04.08 US

Filing date 3 April 2009

Wipo publication date 15 October 2009

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

28 October 2010 PCT application entered the National Phase

  PCT publication WO2009/126232 Priority application(s): WO2009/126232

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009234412-Digital content library service

2009234402-Hydroprocessing using rejuvenated supported hydroprocessing catalysts